Career Center



  BayBio: VC Spotlight | Changing Biotech Business Models
Date:   Thursday, January 27, 2011
Time:   3:30-6:30PM

South San Francisco Conference Center
255 South Airport Blvd
South San Francisco, CA

Sponsor:   BayBio
Event details:  

A wave of generic drugs based on today’s top blockbusters, the expansion of personalized medicine, fundamental healthcare reform in the United States, and the continued globalization of the industry – on top of a global financial crisis – have made the standard biotech business model unsustainable. How can the industry change the ways in which drugs are developed and commercialized? What are the alternative business models? What is the goal (fail early and cheap)? And are investors driving change in behavior? A panel of seasoned investors – VCs, angels, and corporate investors – will reflect on investments made over the last two years and during the 2011 JP Morgan Healthcare Conference, highlighting what life science entrepreneurs should expect ahead. Q&A and networking will provide an opportunity to better understand and form a successful relationship with investors.

Moderator: Simeon J. George, M.D.
Partner, SR One


Brian Atwood
Managing Director
Versant Ventures
Michael J. Finney, PhD
Finney Capital
Karl Handelsman
Managing Director, Life Sciences
CMEA Capital

Additional information and/or registration:  

Registration required. Sliding scale for BayBio members and non-members. More information available here.


Footer Links: